Steve Harr

Co-founder and President and Chief Executive Officer at Sana Biotechnology
Seattle

GeekWire Summit: Sana CEO reveals details about stealthy gene therapy startup

Founded by veterans of Juno Therapeutics, Sana Biotechnology is developing new ways to modify genes and replace damaged cells in the body, possibly pioneering new treatments for a number of diseases. Sana CEO Steve Harr shed more light on one of most secretive, heavily funded startups in Seattle and the global biotech industry during this fireside chat at the GeekWire Summit. Originally shown October 22, 2020. Moderated by Luke Timmerman, The Timmerman Report.

Organizations